Iran issues permit for emergency use of Chinese coronavirus vaccine

A spokesperson for the Food and Drug Administration announced the issuance of an emergency use permit for the Chinese Sinopharm vaccine in Iran and said that there is currently no prohibition on its distribution and inoculation.
Previously, the permit for the import and emergency use of this vaccine was issued conditionally, but on Wednesday, March 10, IRNA news agency quoted Kianoush Jahanpour as saying that "after completing the technical information and documentation and reviewing it at the Food and Drug Administration, a permit for its emergency use in the country has been issued, and there is currently no prohibition on its distribution and inoculation."
The news of issuing an emergency use permit for the Chinese coronavirus vaccine comes at a time when the country is under pressure from the international community for its secrecy regarding the spread of the coronavirus and its origin.
A member of the World Health Organization team that traveled to China last month to investigate the origins of the coronavirus said the country had refused to provide raw data on the 174 people China first reported infected with the coronavirus in the city of Wuhan.
In February, Iranian media reported that Iran and Russia had reached an agreement to launch a joint production line for the Sputnik V vaccine in the country. So far, two shipments of this vaccine have arrived in Iran.
The Islamic Republic had previously reached an agreement with Cuba to launch a vaccine production line produced by the country in Iran, and Cuba had announced that it had signed an agreement with Iran to transfer knowledge on the production of the coronavirus vaccine and would conduct the final stage of clinical testing of the vaccine produced by the country on the Iranian people.
Source: Radio Farda




